Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Cervical Cancer
- Breast Cancer
- Esophageal Cancer
- Gastric Cancer
- Hepatocellular Carcinoma
- Melanoma
- Squamous Cell Cancer
- Merkel Cell Carcinoma
- Urothelial Carcinoma
- Microsatellite Instability High
- Non -Small Cell Lung Cancer
- Ovarian Cancer
- Small Cell Lung Cancer
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: Non-RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04116320
- Collaborators
- Theraclion
- Investigators
- Principal Investigator: Lynn Dengel, MD, MSc University of Virginia